KATIE JOY SUDA, PHARM.D.

FR-Associate Professor
Preventive Medicine

Office: 340 Pharmacy Building
Tel: (901) 448-3744
ksuda@uthsc.edu

Education

  • None, ACCP, Focused Investigator Training (F.I.T.)
  • Other, American Association of Colleges of Pharmacy, Academic Leadership Fellows Program (ALFP)
  • M.S., University of Tennessee Health Science Center, Epidemiology
  • , University of Illinois at Chicago, Fellowship - Infectious Diseases and Outcomes
  • , Clinical Pharmacokinetics Laboratory, Fellowship - Pharmacokinetics
  • , Baptist Memorial Health Care, Residency - Pharmacy Practice
  • Pharm.D., Drake University College of Pharmacy, Pharmacy

Research interest/specialty

My research specialty is analyzing large datasets for medication utilization and infectious disease diagnoses. Please review my research description for my primary and secondary research interests.

Research keywords

Outcomes
Epidemiology
Medication Utilization
Prescribing Patterns
Quality of Health Information

Research interest/specialty

My research specialty is analyzing large datasets for medication utilization and infectious disease diagnoses. Please review my research description for my primary and secondary research interests.

Research keywords

Outcomes Epidemiology Medication Utilization Prescribing Patterns Quality of Health Information

Research description

My primary research interest has been in clinical outcomes research. Recent projects includes investigating risk factors for hemodialysis patients with methicillin resistant Staphylococcus aureus, improve treatment options against Candida, evaluate differences in outcomes in hospitalized patients with cancer, and promote stewardship in the treatment of respiratory tract infections. My secondary research interest has been in the area of medical information; specifically the quality of medical information. I have incorporated this research into my practice site. This includes evaluating the completeness of meta-analysis authors'' search strategy, gender disparities in publications in pharmacy journals, and incidence of non-inferiority studies over a ten-year period.

Publications

  1. Gharbawy, D, Tadrous, M, Suda, K. Does depression lead to influenza? - A systematic literature analysis. J Affect Disord, 138 (1-2), 41-5, 2012.
  2. St. Onge E, Suda KJ, Devaud L, Wilson A, Dutta A, Sacks G, Bricker JD.. “Approaches to Management of Dilemmas by Leaders in Academic Pharmacy.”. Currents in Pharmacy Teaching and Learning., 4, 78-83, 2012.
  3. Farland MZ, Franks A, Thomas J, Byrd D, Suda KJ.. “Development of a Primary Care Pharmacist Practice Based Research Network.”. Currents in Pharmacy Teaching and Learning., 4, 150-154, 2012.
  4. Suda, KJ, Wiskirchen, DE, Advincula, R. Improving safe and appropriate use of antibiotics. J Am Pharm Assoc (2003), 52 (1), 6-10, 2012.
  5. Suda, KJ, Bell, GC, Franks, AS. Faculty and student perceptions of effective study strategies and materials. Am J Pharm Educ, 75 (10), 201, 2011.
  6. Balderson, BJ, Yates, ME, Patil, NP, Suda, KJ. Evaluation of doripenem utilization and susceptibilities at a large urban hospital. Int J Clin Pharm, 33 (6), 958-63, 2011.
  7. Crane, JH, Suda, KJ. Oxycodone induced delirium and agitation in an elderly patient following total right knee arthroplasty. Int J Clin Pharm, 33 (5), 733-6, 2011.
  8. Suda, KJ, Hurley, AM, McKibbin, T, Motl Moroney, SE. Publication of noninferiority clinical trials: changes over a 20-year interval. Pharmacotherapy, 31 (9), 833-9, 2011.
  9. Vo, KH, Waddell, JA, Suda, KJ. Rapid development of infusion-related severe hypotension during rituximab therapy. Ann Pharmacother, 45 (5), e29, 2011.
  10. Tadrous M, Gharbawy DE, Hurley A, Miller E, Suda KJ.. “Establishing a Complete Drug Information Triad: Academic, Industry, and Hospital Training.”. Drug Information Journal., 45, 641-644, 2011.
  11. Poston RS, Suda KJ, Onita C. How Experts Answer Drug-Related Questions Using Online and Offline Sources.. e-Services Journal., 6 (3), 3-39, 2009.
  12. Wang, J, Mullins, CD, Zuckerman, IH, Walker, GD, Suda, KJ, Yang, Y, White-Means, SI. Medical Expenditure Panel Survey: a valuable database for studying racial and ethnic disparities in prescription drug use. Res Social Adm Pharm, 4 (3), 206-17, 2008.
  13. Wang, J, Dong, Z, Hong, SH, Suda, KJ. A comparison of direct medical costs across racial and ethnic groups among children with cancer. Curr Med Res Opin, 24 (3), 847-58, 2008.
  14. Garey, KW, Pai, MP, Suda, KJ, Turpin, RS, Rege, MD, Mingo, DE, Bearden, DT. Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiol Drug Saf, 16 (8), 919-27, 2007.
  15. Garey, KW, Turpin, RS, Bearden, DT, Pai, MP, Suda, KJ. Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study. Int J Antimicrob Agents, 29 (5), 557-62, 2007.
  16. Chen, H, Suda, KJ, Turpin, RS, Pai, MP, Bearden, DT, Garey, KW. High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis. Curr Med Res Opin, 23 (5), 1057-65, 2007.
  17. Maclayton, DO, Suda, KJ, Coval, KA, York, CB, Garey, KW. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther, 28 (8), 1208-16, 2006.
  18. Garey, KW, Rege, M, Pai, MP, Mingo, DE, Suda, KJ, Turpin, RS, Bearden, DT. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis, 43 (1), 25-31, 2006.
  19. Motl, SE, Suda, KJ, Kuth, JC, Gladney, TJ. Racial comparison of outcomes and costs for inpatient neutropenic patients: a multicenter evaluation. J Oncol Pract, 2 (2), 53-6, 2006.
  20. Bridges JD, Nettle CB, Suda KJ, Patel V, Dugirrala VJ, Garey KW. Low-dose Granisetron for the Prevention of Post-operative Nausea and Vomiting: A Prospective, Double-blind, Randomized Study. Journal of Applied Research, 6 (3), 223-229, 2006.
  21. Motl SE, Suda KJ, Kuth JC. Racial Comparison of Outcomes and Costs of Inpatient Neutropenic Patients: A Multicenter Evaluation. Journal of Oncology Practice, 2 (2), 53-56, 2006.
  22. Suda KJ, Motl SE, Kuth JC. Inpatient Oncology Length of Stay and Hospital Costs: Implications for Rising Inpatient Expenditure. Journal of Applied Research, 6 (2), 126-131, 2006.
  23. Suda, KJ, Garey, KW, Danziger, LH. Treatment failures secondary to drug interactions with divalent cations and fluoroquinolone. Pharm World Sci, 27 (2), 81-2, 2005.
  24. ACCP Infectious Diseases Practice Research Network Bibliography Group (Aeschlimann J, Allen GP, Bearden D, Brock J, Carver P, Clay P, Daftary MN, Destache C, Gelone S, Griim SA, Hall RG, Herring T, Jaso T, Johnson JW, Kishel J, Lee J, McCoy C, Mohr J, Pasquale T, Segarra-Newnham M, Suda KJ, Villman M, Yang K). Key References on Infectious Diseases Pharmacotherapy. Pharmacotherapy, 24 (11), 1586-1593, 2004.